KPV Peptide Reduces Crystal-Induced Inflammation as Effectively as Full Alpha-MSH
The tripeptide KPV (alpha-MSH 11-13) reduced crystal-induced peritonitis as effectively as full-length alpha-MSH when administered systemically, confirming the C-terminal fragment retains the complete anti-inflammatory activity.
Quick Facts
What This Study Found
KPV (alpha-MSH 11-13) reduced crystal-induced peritonitis as effectively as full-length alpha-MSH via systemic administration, with melanocortin receptor-independent anti-inflammatory activity at the inflammation site.
Key Numbers
How They Did This
Animal study using crystal-induced peritonitis model. Systemic administration of alpha-MSH, KPV (11-13), core peptide HFRW (6-9), and fragments. Inflammatory cell infiltration and cytokine production measured.
Why This Research Matters
A 3-amino-acid peptide with full anti-inflammatory activity is incredibly practical for drug development — tiny, cheap to produce, and potentially orally bioavailable.
The Bigger Picture
KPV demonstrates that nature's most essential anti-inflammatory signal can be captured in just three amino acids. This efficiency is remarkable and makes KPV one of the most practical peptide drug candidates.
What This Study Doesn't Tell Us
Mouse peritonitis model. The melanocortin receptor-independent mechanism needs further characterization. Systemic dosing — local delivery effects not compared.
Questions This Raises
- ?Can oral KPV achieve anti-inflammatory concentrations?
- ?What is KPV's non-melanocortin receptor anti-inflammatory mechanism?
- ?Could KPV treat gout and other crystal-induced diseases?
Trust & Context
- Key Stat:
- 3 amino acids = full effect KPV matched 13-amino-acid alpha-MSH for anti-inflammatory activity — nature's most compact anti-inflammatory signal
- Evidence Grade:
- Moderate evidence from a controlled animal inflammation model with direct comparison to full-length peptide.
- Study Age:
- Published in 2003. KPV's anti-inflammatory properties have been further validated, with growing clinical interest for IBD and other inflammatory conditions.
- Original Title:
- Dissection of the anti-inflammatory effect of the core and C-terminal (KPV) alpha-melanocyte-stimulating hormone peptides.
- Published In:
- The Journal of pharmacology and experimental therapeutics, 306(2), 631-7 (2003)
- Authors:
- Getting, Stephen J, Schiöth, Helgi B(3), Perretti, Mauro
- Database ID:
- RPEP-00820
Evidence Hierarchy
Tests effects in animals (usually mice or rats), not humans.
What do these levels mean? →Frequently Asked Questions
What is KPV?
Just three amino acids (Lys-Pro-Val) from the end of alpha-MSH. Despite being incredibly tiny, it has the full anti-inflammatory power of the complete 13-amino-acid peptide.
Could KPV treat gout?
This study models gout-like crystal inflammation, and KPV was highly effective. Its anti-inflammatory mechanism — which doesn't require melanocortin receptors at the inflammation site — makes it a promising candidate for crystal diseases like gout.
Read More on RethinkPeptides
Cite This Study
https://rethinkpeptides.com/research/RPEP-00820APA
Getting, Stephen J; Schiöth, Helgi B; Perretti, Mauro. (2003). Dissection of the anti-inflammatory effect of the core and C-terminal (KPV) alpha-melanocyte-stimulating hormone peptides.. The Journal of pharmacology and experimental therapeutics, 306(2), 631-7.
MLA
Getting, Stephen J, et al. "Dissection of the anti-inflammatory effect of the core and C-terminal (KPV) alpha-melanocyte-stimulating hormone peptides.." The Journal of pharmacology and experimental therapeutics, 2003.
RethinkPeptides
RethinkPeptides Research Database. "Dissection of the anti-inflammatory effect of the core and C..." RPEP-00820. Retrieved from https://rethinkpeptides.com/research/getting-2003-dissection-of-the-antiinflammatory
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.